News

Strand claimed that Avadis NGS helps biologists visualise and perform downstream analysis on their NGS data, simply on a desktop computer. The introduction of sequencing technologies has resulted

Prior to joining NGM Biopharmaceuticals, Rieflin was the president of XenoPort, and currently serves on XenoPort’s board of directors. NGM Biopharmaceuticals chairman David Goeddel said that they are

Convergence Pharmaceuticals has recently raised $35.4m in Series A financing from a syndicate of European and US life science investors. Under the terms of the agreement, Convergence Pharmaceuticals

Most recently, Welch was the chief financial officer at Cerimon Pharmaceuticals, a Pharmaceutical company engaged in developing pain products. Prior to joining, Cerimon, Welch was the chief financial

According to the report filed with the Bombay Stock Exchange, the Mumbai-based company will increase its board presence to five seats from the previous two in the seven-member

A generic version of Bristol Myers Squibb’s Reyataz capsules, Atazanavir Sulfate capsules are used in conjunction with the other medications to control HIV infection and is included in

The company has recruited around 1500 women two months ahead of schedule at over 100 sites throughout the US. Following the completion of the the patient recruitment, Agile

Under the contract, Evotec is expected to use its fragment-based drug discovery platform, EVOlution to the programme, which will used to investigate protein-protein interactions on targets selected by

Moreau brings 26 years of diverse marketing, sales, business development, funding, investor relations, client relations, communications and operations management experience to Miraculins, having held senior executive positions in